Study dispels myth that cancer biopsies cause cancer spread
the ONA take:
According to a new study published in the journal Gut, researchers at the Mayo Clinic in Jacksonville, Florida, have found that cancer biopsies do not cause cancer to spread and that patients who underwent a biopsy had better outcomes than those who did not receive one.
For the study, researchers analyzed the Medicare data of over 2,000 patients with non-metastatic pancreatic cancer who underwent surgery for their disease. Of those, about approximately 500 had an ultrasound-guided fine needle aspiration, while the other 1,500 did not.
Results showed that during a median follow-up time of 21 months, 57% of those who received a biopsy and 76% of those that did not died. Fifty percent of those in the biopsy group compared with 64% of the non-biopsy group were found to have died as a result of pancreatic cancer.
Furthermore, the median overall survival in the biopsy group was 22 months versus 15 months in the non-biopsy group. The findings suggest that the minimally invasive fine needle aspiration technique does not causes cancer to spread, and undergoing a biopsy even improves mortality and overall survival.
This study does not only apply to those with pancreatic cancer as the fine needle aspiration technique is used across various tumor types.
Cancer biopsies do not cause cancer to spread.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|